6 days Ago By Defense World Staff
Renaissance Technologies LLC cut its position in shares of Cardlytics, Inc. (NASDAQ:CDLX – Free Report) by 1.8% in the fourth quarter, according to the company in its most recent disclosure with the SEC.
The institutional investor owned 403,414 shares of the company’s stock after selling 7,521 shares during the quarter. Renaissance Technologies LLC owned 0.79% of Cardlytics worth $1,497,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Tallon Kerry Patrick acquired a new stake in shares of Cardlytics in the fourth quarter valued at approximately $37,000. Virtu Financial LLC bought a new stake in Cardlytics during the 4th quarter worth about $62,000.
Intech Investment Management LLC boosted its stake in shares of Cardlytics by 31.3% during the 4th quarter. Intech Investment Management LLC now owns 19,310 shares of the company’s stock worth $72,000 after buying an additional 4,607 shares during the last quarter.
SG Americas Securities LLC grew its holdings in shares of Cardlytics by 38.2% in the 4th quarter. SG Americas Securities LLC now owns 19,490 shares of the company’s stock valued at $72,000 after acquiring an additional 5,392 shares in the last quarter.
Finally, Global Retirement Partners LLC increased its position in shares of Cardlytics by 54.7% in the fourth quarter. Global Retirement Partners LLC now owns 19,800 shares of the company’s stock valued at $73,000 after acquiring an additional 7,000 shares during the last quarter.
Institutional investors and hedge funds own 68.10% of the company’s stock. Cardlytics Trading Down 4.
0 %CDLX opened at $1.45 on Tuesday. The stock has a market capitalization of $75.
65 million, a price-to-earnings ratio of -0.24 and a beta of 1.39.
The company has a quick ratio of 1.18, a current ratio of 1.18 and a debt-to-equity ratio of 2.
40. Cardlytics, Inc. has a twelve month low of $1.
22 and a twelve month high of $15.89. The company has a 50-day simple moving average of $1.
96 and a 200 day simple moving average of $3.09. Analysts Set New Price TargetsSeveral research firms have issued reports on CDLX.
Lake Street Capital dropped their price objective on Cardlytics from $5.00 to $3.00 and set a “hold” rating on the stock in a research note on Thursday, March 13th.
Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research note on Thursday, March 13th. Finally, Evercore ISI cut their price objective on shares of Cardlytics from $4.00 to $3.
00 and set an “in-line” rating for the company in a report on Thursday, March 13th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has assigned a strong buy rating to the stock. According to MarketBeat.
com, the stock has a consensus rating of “Hold” and a consensus target price of $6.42.View Our Latest Report on CardlyticsInsider ActivityIn other Cardlytics news, CFO Alexis Desieno sold 24,778 shares of the firm’s stock in a transaction on Tuesday, February 18th.
The stock was sold at an average price of $3.40, for a total value of $84,245.20.
Following the sale, the chief financial officer now owns 140,948 shares of the company’s stock, valued at approximately $479,223.20. This trade represents a 14.
95 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Amit Gupta sold 46,857 shares of the business’s stock in a transaction on Tuesday, February 18th.
The stock was sold at an average price of $3.40, for a total value of $159,313.80.
Following the transaction, the chief executive officer now directly owns 418,637 shares of the company’s stock, valued at $1,423,365.80. This trade represents a 10.
07 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 75,315 shares of company stock worth $254,789.
4.40% of the stock is currently owned by corporate insiders. About Cardlytics (Free Report)Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom.
It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.Featured StoriesFive stocks we like better than CardlyticsHow Investors Can Find the Best Cheap Dividend StocksBest Defense Stocks in 2025..
. So FarHow to Use the MarketBeat Stock Screener Alphabet Rebounds After Strong Earnings and Buyback AnnouncementHow to Calculate Stock Profit Could Selling Taiwan Semiconductor Be Buffett’s Biggest Regret?Want to see what other hedge funds are holding CDLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardlytics, Inc.
(NASDAQ:CDLX – Free Report)..
